We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CELLDEMIC (Seqirus Pty Ltd)
Product name
CELLDEMIC
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
210 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/ NBE
Indication
CELLDEMIC® is indicated for active immunisation against the H5 subtype of Influenza A virus in persons from 6 months of age and older.